iCura Diagnostics, Inc.

LinkedIn

Phone: +1 484-588-6055

Web: www.icuradx.com

Under the leadership of board-certified pathologists and PhD-level scientists, iCura offers a broad portfolio of services tailored for drug development, translational research, and clinical trials. These include:

• Digital pathology (whole slide imaging, IHC, FISH, CISH, RNAscope) with quantitative analysis. 
• Routine histology, including IHC assays for H score development and validation. IVD IHC assays for oncology predicative markers such as PD-L1, Her-2, ER, PR, Trop2, Claudin 18.2, Folate Receptor alpha, etc.
• Multiplex immunofluorescence (mIF) panels, including panels designed for tumor microenvironment, spatial biology, tissue on- and off-target drug distributions, etc.. 
• Genomics services: NGS, digital PCR, quantitative PCR, whole transcriptome, spatial transcriptomics and custom pipelines. 
• Clinical trial logistics and sample management including lab manuals, site training, and transportation support. 
• Recognised as the first multiplex IHC/IF service partner fully qualified by Akoya Biosciences, confirming our high quality and CRO focus. 

For detailed contact information visit location pages below.